Pricing Log in Create free account
Saturday 17 October 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IQVIA Holdings Inc. (IQV) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 23, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Sep 9, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 10 added · 7 removed · 20 modified
P2I1A: no material changes, the filing says
8-K Jul 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 11, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Jun 4, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jun 3, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 7, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 23, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits Officer departure
10-K Dec 31, 2025 1: 9 added · 16 removed · 22 modified
1A: 9 added · 3 removed · 27 modified
7: 12 added · 7 removed · 22 modified
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 9, 2025 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Nov 5, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 2, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.